Report Library
All Reports2015 Post-ADA Report - Part II, Supplement
July 28, 2015
Part II of our 2015 Post-ADA Report provides:
- Highlights from a pulse survey we conducted among primary care physicians on the FDA warning about diabetic ketoacidosis
(DKA) with SGLT2 Inhibitors in Type 2 diabetics. For opinions from endocrinologists, please see Part I of the 2015 Post-ADA Report. For the full survey,
please see this link.
- An analysis of all the industry-sponsored trials presented at the 2015 ADA conference from Citeline’s Trialtrove®. This includes number of abstracts, clinical phases, diseases covered, top drugs, and locations of trials.
Indications Covered: | Complement Deficiencies / Abnormalities |
Additional Resources: